D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Qualcomm
QCOM
|
+$555M |
| 2 |
Marathon Petroleum
MPC
|
+$538M |
| 3 |
Ford
F
|
+$529M |
| 4 |
Walmart
WMT
|
+$508M |
| 5 |
Apple
AAPL
|
+$499M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$716M |
| 2 |
Merck
MRK
|
+$498M |
| 3 |
Meta Platforms (Facebook)
META
|
+$425M |
| 4 |
McDonald's
MCD
|
+$369M |
| 5 |
Wells Fargo
WFC
|
+$362M |
Sector Composition
| 1 | Technology | 20.88% |
| 2 | Consumer Discretionary | 13.12% |
| 3 | Healthcare | 9.93% |
| 4 | Communication Services | 9.58% |
| 5 | Financials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Acushnet Holdings
GOLF
$4.38B
| $6.8M | 0.01% |
137,724
+86,317
| +168% | +$4.26M |
|
|
ACBI
1127
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $6.8M | 0.01% |
267,181
-19,332
| -7% | -$492K |
|
1128
Matthews International
MATW
$763M
| $6.77M | 0.01% |
188,379
-32,945
| -15% | -$1.18M |
|
1129
Prospect Capital
PSEC
$1.29B
| $6.77M | 0.01% |
+806,438
| New | +$6.77M |
|
1130
Sotera Health
SHC
$4.56B
| $6.77M | 0.01% |
279,187
-112,050
| -29% | -$2.72M |
|
|
PDCO
1131
DELISTED
Patterson Companies, Inc.
PDCO
| $6.75M | 0.01% |
222,077
+173,223
| +355% | +$5.26M |
|
|
PRSU
1132
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $6.75M | 0.01% |
135,366
-76,506
| -36% | -$3.81M |
|
1133
Danaher
DHR
$136B
| $6.75M | 0.01% |
28,351
-114,902
| -80% | -$27.3M |
|
1134
Trex
TREX
$6.48B
| $6.73M | 0.01% |
65,836
+59,796
| +990% | +$6.11M |
|
1135
California Resources
CRC
$4.44B
| $6.71M | 0.01% |
+222,560
| New | +$6.71M |
|
1136
AnaptysBio
ANAB
$655M
| $6.71M | 0.01% |
258,644
-36,950
| -13% | -$958K |
|
1137
Trinity Industries
TRN
$2.28B
| $6.71M | 0.01% |
249,443
-147,152
| -37% | -$3.96M |
|
|
TCS
1138
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $6.71M | 0.01% |
34,283
-4,077
| -11% | -$797K |
|
1139
Kellanova
K
$27.6B
| $6.7M | 0.01% |
110,924
+72,763
| +191% | +$4.4M |
|
|
OHPAU
1140
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $6.68M | 0.01% |
673,666
+563,108
| +509% | +$5.59M |
|
|
ROSS.U
1141
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
| $6.68M | 0.01% |
669,540
+93,274
| +16% | +$930K |
|
1142
Veracyte
VCYT
$2.43B
| $6.66M | 0.01% |
166,543
-16,061
| -9% | -$642K |
|
|
QUOT
1143
DELISTED
Quotient Technology Inc
QUOT
| $6.66M | 0.01% |
615,862
-47,405
| -7% | -$512K |
|
1144
DraftKings
DKNG
$21.8B
| $6.65M | 0.01% |
127,514
+34,024
| +36% | +$1.77M |
|
|
CZOO
1145
DELISTED
Cazoo Group Ltd
CZOO
| $6.62M | 0.01% |
+333
| New | +$6.62M |
|
1146
Dollar General
DG
$23B
| $6.6M | 0.01% |
30,513
-24,995
| -45% | -$5.41M |
|
1147
Reinsurance Group of America
RGA
$12.7B
| $6.59M | 0.01% |
57,766
+55,796
| +2,832% | +$6.36M |
|
1148
Talphera
TLPH
$19.3M
| $6.58M | 0.01% |
238,426
-24,018
| -9% | -$663K |
|
1149
Cerus
CERS
$236M
| $6.58M | 0.01% |
1,113,010
+343,602
| +45% | +$2.03M |
|
1150
Denali Therapeutics
DNLI
$2.07B
| $6.56M | 0.01% |
83,585
-122,577
| -59% | -$9.62M |
|